![]() |
SARS-CoV-2 Vaccines and Neurodegenerative Disease |
Since December 2020, when several novel unprecedented vaccines against SARS-CoV-2 began to be approved for emergency use, there has been a worldwide effort to get these vaccines into the arms of as many people as possible as fast as possible. These vaccines have been developed "at warp speed," given the urgency of the situation with the COVID-19 pandemic. |
Jun 01, 2021
by
Stephanie Seneff - StephanieSeneff.net
Science & Medicine Blogs |